NHL Alumni Association, NEEKA Health Canada and Canopy Growth have announced a transformative clinical research partnership that will investigate the efficacy of cannabinoids as an integral part of a novel treatment for post-concussion neurological diseases in former NHL players. The study will undertake the rigorous science needed to establish the medicinal value of cannabis when combined with other proven treatments amongst this highly-afflicted group of elite athletes and potentially improve their ability to interact with family, friends and their communities. Approximately 100 former players will be enrolled in this randomized double-blind study. The study is expected to begin in summer 2019 and will take one year to complete.